[1] BERTAINA A,ZECCA M,BULDINI B,et al.Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia[J].Blood,2018,132(24):2594-2607.
[2] SULTAN S,VACHON M F,CHARETTE M C,et al.A comparison of attitudes toward HSCT and survival estimations post HSCT across two pediatric Hematology-Oncology and Intensive Care departments in Canada[J].Bone Marrow Transplant,2018,53(4):511-514.
[3] 王顺清. 造血干细胞移植治疗重型再生障碍性贫血进展[J].临床血液学杂志,2021,34(9):613-617.
[4] BOOTH G S,GEHRIE E A,BOLAN C D,et al.Clinical guide to ABO-incompatible allogeneic stem cell transplantation[J].Biol Blood Marrow Transplant,2013,19(8):1152-1158.
[5] KUROSAWA S,YAMAGUCHI T,NAKABAYASHI S,et al.Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation[J].Int J Hematol,2021,113(4):518-529.
[6] YAMAMOTO F.Review:ABO blood group system—ABH oligosaccharide antigens,anti-A and anti-B,A and B glycosyltransferases,and ABO genes[J].Immunohematology,2004,20(1):3-22.
[7] KOMINATO Y,HATA Y,MATSUI K,et al.Transcriptiona
l regulation of the human ABO histo-blood group genes is dependent on the N box upstream of the proximal promoter[J].Transfusion,2004,44(12):1741-1749.
[8] ROWLEY S D,DONATO M L,BHATTACHARYYA P.Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation[J].Bone Marrow Transplant,2011,46(9):1167-1185.
[9] KIMURA F,SATO K,KOBAYASHI S,et al.Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program[J].Haematologica,2008,93(11):1686-1693.
[10] TESHIGAWARA-TANABE H,HAGIHARA M,MATSUMURA A,et al.Passenger lymphocyte syndrome after ABO-incompatible allogeneic hematopoietic stem cell transplantation;dynamics of ABO allo-antibody and blood type conversion[J].Hematology,2021,26(1):835-839.
[11] Red Cell Immunogenetics and Blood Group Terminology.International Society of Blood Transfusion Working Party[EB/OL].(2023-06).https://www.isbtweb.org/isbt-working-parties/rcibgt.html.
[12] BOOTH G S,GEHRIE E A,BOLAN C D,et al.Clinical guide to ABO-incompatible allogeneic stem cell transplantation[J].Biol Blood Marrow Transplant,2013,19(8):1152-1158.
[13] 黄晓军. 实用造血干细胞移植[M].北京:人民卫生出版社, 2018;124-129.
[14] Claudia S.Cohn.AABB Technical Manual(20th edition) [M].Bethesda, MD:AABB Press, 2020.
[15] FOUKANELI T,KERR P,BOLTON-MAGGS P H B,et al.Guidelines on the use of irradiated blood components[J].Br J Haematol,2020,191(5):704-724.
[16] 蔡雪娇,陈碧乐,谢作听,等.ABO血型不合的异基因造血干细胞移植骨髓空虚期血型的血清学特性研究[J].中国实验血液学杂志,2016,24(1):221-224.
[17] 包旻翰,刘毅智,陈学军,等.造血干细胞移植儿童ABO血型不合对造血重建的影响和血型转换规律的变化[J].中国输血杂志,2020,33(10):1007-1012.
[18] 高雨菡,田文沁.ABO血型不合造血干细胞移植患者的血型格局变化及其输血策略[J].北京医学,2017,39(6):637-640.
[19] CURLEY C,PILLAI E,MUDIE K R,et al.Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange[J].Transfusion,2012,52(2):291-297.
[20] LI Z Z,CZECHOWICZ A,SCHECK A,et al.Hematopoiet
ic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation[J].Nat Commun,2019,10:616.
[21] SATWANI P,JIN Z Z,DUFFY D,et al.Transplantation-related mortality,graft failure,and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients[J].Biol Blood Marrow Transplant,2013,19(4):552-561.
[22] MIDDELBURG R A,KERKHOFFS J L H,VAN DER BOM J G.Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients:a simulation study exploring underlying mechanisms[J].Clin Epidemiol,2018,10:401-411.
[23] KONUMA T,OIWA-MONNA M,MIZUSAWA M,et al.Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantation[J].Bone Marrow Transplant,2019,54(11):1836-1846.
[24] 中华人民共和国国家卫生健康委员会.内科输血[S].2018.
[25] 中华人民共和国国家卫生健康委员会.儿科输血指南[S].2022.
[26] SEVER T,KIRKIZ S,KAYA Z,et al.Impact of peri-transplant RBC transfusion and ABO incompatibility on acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients[J].Transfus Apher Sci,2022,61(3):103352.
[27] MIDDELBURG R A,KERKHOFFS J L H,VAN DER BOM J G.Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients:a simulation study exploring underlying mechanisms[J].Clin Epidemiol,2018,10:401-411.
[28] SATO N,MARUBASHI S.How is transfusion-associated graft-versus-host disease similar to,yet different from,organ transplantation-associated graft-versus-host disease?[J].Transfus Apher Sci,2022,61(2):103406.
[29] NOLLET K E,NGOMA A M,OHTO H.Transfusion-associated graft-versus-host disease,transfusion-associated hyperkalemia,and potassium filtration:advancing safety and sufficiency of the blood supply[J].Transfus Apher Sci,2022,61(2):103408.
[30] 闻才李,王思贤,张慧,等.国内Rh血型系统E、e、C、c抗原同型输注现状[J].临床检验杂志,2023,41(2):139-141.
[31] 江晓明,杜平,陈烨.Rh血型抗原CcEe在临床输血中的意义[J].临床输血与检验,2018,20(6):648-650.
[32] SHAO C P,ZHAO C J,WU C L,et al.Rh-matched transfusion through molecular typing for β-thalassemia patients is required and feasible in Chinese[J].Transfus Med Hemother,2018,45(4):252-257.
[33] ESTCOURT L J,STANWORTH S,DOREE C,et al.Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation[J].Cochrane Database Syst Rev,2015,2015(10):CD010984.
[34] 中国医师协会输血科医师分会,中华医学会临床输血学分会.血小板抗体检测专家共识[J].临床输血与检验,2020,22(1):1-5.
[35] 中国医师协会输血科医师分会,中华医学会临床输血学分会.特殊情况紧急抢救输血推荐方案[J].中国输血杂志,2014,27(1):1-3.
[36] 上海市医学会输血专科分会,上海市临床输血质量控制中心.紧急抢救时ABO血型不相同血小板输注专家共识[J].中国输血杂志,2017,30(7):666-667. |
